ASH Ashland Global Holdings Inc.

Ashland sets date for first-quarter fiscal 2025 earnings release and conference call webcast

Ashland sets date for first-quarter fiscal 2025 earnings release and conference call webcast

WILMINGTON, Del., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its first-quarter fiscal 2025 earnings release at approximately 5 p.m. ET on Tuesday, January 28, 2025. The company’s live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 9 a.m. ET on Wednesday, January 29. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at .

Among those participating in the webcast presentation will be:

  • Guillermo Novo, chair, and chief executive officer
  • Kevin Willis, senior vice president and chief financial officer
  • Dago Caceres, senior vice president, general manager, specialty additives
  • Alessandra Faccin, senior vice president, general manager, life sciences and intermediates
  • Jim Minicucci, senior vice president, general manager, personal care
  • William Whitaker, vice president finance and director, investor relations

To access the call by phone, please go to and you will be provided with dial in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time.

The webcast and supporting materials will be accessible through the Investor Relations section of Ashland's website at . Following the live event, an archived version of the webcast and supporting materials will be available on the Ashland website for 12 months.

About Ashland 

Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG). The company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceutical. Approximately 3,200 passionate, tenacious solvers – from renowned scientists and research chemists to talented engineers and plant operators – thrive on developing practical, innovative and elegant solutions to complex problems for customers in more than 100 countries. Visit  and to learn more.

™ Trademark, Ashland, or its subsidiaries, registered in various countries.

FOR FURTHER INFORMATION:

Investor Relations:Media Relations:
William WhitakerCarolmarie C. Brown
+1 (614) 790-2095+1 (302) 995-3158

Attachment



EN
14/01/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ashland Global Holdings Inc.

 PRESS RELEASE

Ashland expands pharmaceutical plant for Aquarius™ tablet coatings and...

Ashland expands pharmaceutical plant for Aquarius™ tablet coatings and commissions new microbial protection capability in Brazil, demonstrating strategy to globalize, innovate, and invest Increased production capacity and market presence expected to drive competitive position and organic growth; follows previous investments in Ireland and China Wilmington, Del., April 01, 2025 (GLOBE NEWSWIRE) -- Ashland has completed a 10-million-dollar expansion of its pharmaceutical manufacturing plant in Cabreúva, Brazil and will celebrate the occasion with a ribbon-cutting ceremony on April 4, 202...

 PRESS RELEASE

Ashland to host 2025 Innovation Day for analysts and investors

Ashland to host 2025 Innovation Day for analysts and investors WILMINGTON, Del., March 28, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) is hosting an Innovation Day for analysts and investors at the company’s Bridgewater, New Jersey facility, Thursday, May 29, 2025. The event will showcase the enhanced capabilities and expanded applications of Ashland's scalable technology platforms. Registration is required, with options to attend via live webcast or in person. Participants will join Ashland’s executive and senior technology team for an in-depth review of the latest developments an...

 PRESS RELEASE

Ashland completes sale of Avoca business to Mane

Ashland completes sale of Avoca business to Mane Wilmington, Del., March 17, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) announced today that it has completed the sale of its Avoca business to Mane effective March 14, 2025. Financial terms of the transaction were not disclosed. The Avoca business supplies sclareolide, a fragrance fixative, and a range of contract manufacturing capabilities from two production facilities in North Carolina and Wisconsin.  The Avoca business line represents the last entity from Ashland’s previous acquisition of Pharmachem. “The Avoca business is a s...

Ashland Inc: 2 directors

Two Directors at Ashland Inc bought/maiden bought 34,444 shares at between 64.000USD and 64.240USD. The significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directo...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch